Immediate Impact
1 by Nobel laureates 25 from Science/Nature 61 standout
Citing Papers
Neutrophils in Cancer immunotherapy: friends or foes?
2024 Standout
Psychedelics reopen the social reward learning critical period
2023 StandoutNature
Works of Imran Alibhai being referenced
Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors.
2023
Regulation of fosB and ΔfosB mRNA expression: In vivo and in vitro studies
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Imran Alibhai | 301 | 359 | 5 | 107 | 11 | 668 | |
| Gwen L. Schafer | 327 | 398 | 14 | 168 | 16 | 767 | |
| Ana I. Herrero | 209 | 303 | 14 | 174 | 10 | 829 | |
| Cecilia Jiang | 295 | 330 | 18 | 96 | 9 | 839 | |
| Rebecca J. Ralph | 352 | 512 | 1 | 102 | 11 | 780 | |
| Sjoukje D. Kuipers | 248 | 434 | 13 | 115 | 12 | 791 | |
| Daniel Beis | 176 | 241 | 6 | 95 | 10 | 591 | |
| Charles Finsterwald | 205 | 256 | 10 | 184 | 11 | 764 | |
| Maria Nordheim Alme | 238 | 358 | 11 | 95 | 8 | 655 | |
| Serdar Demirgören | 394 | 362 | 4 | 139 | 12 | 722 | |
| Katerina V. Savelieva | 340 | 292 | 7 | 79 | 24 | 780 |
All Works
Loading papers...